CEVHAP’s Strategy 2011-2013

There are clear challenges to achieving the eradication of chronic viral hepatitis in the Asia Pacific. These include preventing further transmission; ensuring that people infected with the virus are diagnosed and have access to clinical management for the condition; and ensuring that the health workforce has the skills and resources to respond to people with or at risk of the virus. CEVHAP’S key strategic focus is to improve public policy to change how viral hepatitis is managed across Asia Pacific. We will do this through

  • Advocacy – being an independent voice, connecting with other stakeholders, civil society and governments in calling for a better response to viral hepatitis
  • Policy Development - conducting evidence-based policy and associated research to address data gaps and inform the development of public policy
  • Education - building capacity at a local level by supporting
    local advocates with tools and knowledge to support their advocacy work

To access the CEVHAP Strategic Plan, click here

FaLang translation system by Faboba

 CEVHAP-CUHK Hepatitis Policy in Asia June 2017

>> Viral Hepatitis Asia Survey 2016

 

nohep.logo_horizontal.jpg

NOhep is a global, grassroots movement aimed at bringing all stakeholders together to eliminate viral hepatitis by 2030. It has been developed to create global awareness of the disease, similar to the red ribbon for HIV/AIDS, and was launched in 2016. NOhep firmly positions itself at the forefront of the elimination conversation, showcasing exemplary leadership, fostering on-the-ground innovative solutions and taking action to support the policy changes needed to eliminate this cancer-causing illness by 2030. Being a part of NOhep means being part of the solution. (To find out more about the development of this exciting initiative, watch this short video: https://youtu.be/Oer-rGwnKZU

 

CEVHAP Activity Report Brochure EMAIL smaller Cover

>> 基本概况
病毒性肝炎
全球约有20亿乙肝病毒(HBV)携带者。
由该病毒所致之急性或慢性肝病,平均每
年夺取约60万人生命
如果未经有效治疗,患慢性丙肝及其他
进展性肝病(如肝硬化)之患者比例至2015
年将大幅提升百分之三十八。
目前并无丙肝预防疫苗问世,但约80%
患者可经有效针对性治疗而获痊愈
                                          >>更多信息
>> 视频录影资料
病毒性肝炎所致之全球性健康危害

 

CEVHAP主席陈定信教授

 

Connect with usconnect with CEVHAP